These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16540652

  • 1. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC.
    Cancer Res; 2006 Mar 15; 66(6):3034-43. PubMed ID: 16540652
    [Abstract] [Full Text] [Related]

  • 2. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES, Whigham AS, Yarbrough WG, Weaver AM.
    Cancer Res; 2007 May 01; 67(9):4227-35. PubMed ID: 17483334
    [Abstract] [Full Text] [Related]

  • 3. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA, Jia L, Eves R, Mak AS.
    Eur J Cell Biol; 2007 Apr 01; 86(4):189-206. PubMed ID: 17343955
    [Abstract] [Full Text] [Related]

  • 4. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K.
    Cancer Res; 2009 Nov 15; 69(22):8594-602. PubMed ID: 19887621
    [Abstract] [Full Text] [Related]

  • 5. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
    Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC.
    Exp Cell Res; 2006 May 01; 312(8):1240-53. PubMed ID: 16442522
    [Abstract] [Full Text] [Related]

  • 6. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes.
    Artym VV, Matsumoto K, Mueller SC, Yamada KM.
    Eur J Cell Biol; 2011 May 01; 90(2-3):172-80. PubMed ID: 20656375
    [Abstract] [Full Text] [Related]

  • 7. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.
    Steffen A, Le Dez G, Poincloux R, Recchi C, Nassoy P, Rottner K, Galli T, Chavrier P.
    Curr Biol; 2008 Jun 24; 18(12):926-31. PubMed ID: 18571410
    [Abstract] [Full Text] [Related]

  • 8. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
    Rey M, Irondelle M, Waharte F, Lizarraga F, Chavrier P.
    Eur J Cell Biol; 2011 Jun 24; 90(2-3):128-35. PubMed ID: 20970878
    [Abstract] [Full Text] [Related]

  • 9. Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy.
    Nascimento CF, Gama-De-Souza LN, Freitas VM, Jaeger RG.
    Microsc Res Tech; 2010 Feb 24; 73(2):99-108. PubMed ID: 19658178
    [Abstract] [Full Text] [Related]

  • 10. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
    Lizárraga F, Poincloux R, Romao M, Montagnac G, Le Dez G, Bonne I, Rigaill G, Raposo G, Chavrier P.
    Cancer Res; 2009 Apr 01; 69(7):2792-800. PubMed ID: 19276357
    [Abstract] [Full Text] [Related]

  • 11. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion.
    Castro-Castro A, Janke C, Montagnac G, Paul-Gilloteaux P, Chavrier P.
    Eur J Cell Biol; 2012 Apr 01; 91(11-12):950-60. PubMed ID: 22902175
    [Abstract] [Full Text] [Related]

  • 12. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
    Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC.
    Oncogene; 1999 Aug 05; 18(31):4440-9. PubMed ID: 10442635
    [Abstract] [Full Text] [Related]

  • 13. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.
    Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R.
    J Cell Sci; 2008 Feb 01; 121(Pt 3):369-78. PubMed ID: 18198194
    [Abstract] [Full Text] [Related]

  • 14. Secretory and endo/exocytic trafficking in invadopodia formation: the MT1-MMP paradigm.
    Frittoli E, Palamidessi A, Disanza A, Scita G.
    Eur J Cell Biol; 2011 Feb 01; 90(2-3):108-14. PubMed ID: 20605060
    [Abstract] [Full Text] [Related]

  • 15. The structure of invadopodia in a complex 3D environment.
    Tolde O, Rösel D, Veselý P, Folk P, Brábek J.
    Eur J Cell Biol; 2010 Sep 01; 89(9):674-80. PubMed ID: 20537759
    [Abstract] [Full Text] [Related]

  • 16. A new role for cortactin in invadopodia: regulation of protease secretion.
    Clark ES, Weaver AM.
    Eur J Cell Biol; 2008 Sep 01; 87(8-9):581-90. PubMed ID: 18342393
    [Abstract] [Full Text] [Related]

  • 17. Invadopodia formation in oral squamous cell carcinoma: the role of epidermal growth factor receptor signalling.
    Hwang YS, Park KK, Chung WY.
    Arch Oral Biol; 2012 Apr 01; 57(4):335-43. PubMed ID: 21920495
    [Abstract] [Full Text] [Related]

  • 18. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y, Uekita T, Ito Y, Seiki M, Yamaguchi H, Sakai R.
    Mol Cancer Res; 2013 Jun 01; 11(6):628-37. PubMed ID: 23439492
    [Abstract] [Full Text] [Related]

  • 19. The cortactin-binding domain of WIP is essential for podosome formation and extracellular matrix degradation by murine dendritic cells.
    Bañón-Rodríguez I, Monypenny J, Ragazzini C, Franco A, Calle Y, Jones GE, Antón IM.
    Eur J Cell Biol; 2011 Jun 01; 90(2-3):213-23. PubMed ID: 20952093
    [Abstract] [Full Text] [Related]

  • 20. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.
    Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggiò S, Tetè S, Polishchuk R, Castronovo V, Buccione R.
    Cancer Res; 2009 Feb 01; 69(3):747-52. PubMed ID: 19141649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.